Global Infusion Therapy Devices Market
Medical Equipment

Infusion Therapy Devices Market to Reach $20.11 Billion by 2029 | Key Drivers and Future Outlook

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Infusion Therapy Devices Market?

The market size of infusion therapy devices has experienced a swift expansion in the last few years. The size is set to increase from $12.10 billion in 2024 to $13.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.0%. Factors contributing to the growth during the historical period include a rise in hospital admissions, advancements in healthcare infrastructure, governmental initiatives, growth in medical tourism, and relevant reimbursement policies.

What Growth Rate Is Forecasted for the Infusion Therapy Devices Market by 2029?

The market size for infusion therapy devices is predicted to experience a swift expansion in the coming years, reaching a value of $20.11 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 10.6%. The projected growth during the forecast period can be linked to the influence of personalized medicine, preparedness and response to pandemics, wearable infusion devices, a shift towards infusion therapy, and the digitization of healthcare. Key trends to look out for during this period include 5G connectivity, quantum computing, the incorporation of the internet of things (IoT), wearable health technology, as well as voice assistants and natural language processing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

Which Key Companies Are Shaping the Future of the Infusion Therapy Devices Market?

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Which Factors Are Driving Demand in the Infusion Therapy Devices Industry?

The surge in chronic diseases is anticipated to spur the development of the infusion therapy devices market in the coming times. Chronic diseases are enduring health problems that persist for over a year, requiring routine medical care or restraining daily life activities. The rising occurrence of such diseases could be attributed to poor lifestyle choices, inactive patterns, substandard diets, and environmental elements, along with an increase in risk contributors such as obesity, smoking, and stress. Infusion therapy devices help in managing chronic illnesses by delivering medicaments and fluids directly into the bloodstream with accurate control, ascertaining consistent and effective treatment for disorders such as diabetes, autoimmune diseases, and cancer. This enhances patient outcomes, convenience, and minimizes frequent hospital visits. For instance, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, there would be a remarkable 99.5% increase in people aged 50 or above having at least one chronic illness, escalating from 71.522 million in 2020 to 142.66 million. Hence, the escalating occurrence of chronic diseases is propelling the infusion therapy devices market’s progress.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

How Is the Infusion Therapy Devices Market Segmented by Several Divisions?

The infusion therapy devices market covered in this report is segmented –

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors

2) By Mobility: Portable Infusion Pumps, Stationary Pumps

3) By Application: Oncology, Diabetes, Pain Management, Other Applications

4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:

1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps

2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters

3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas

4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What are the Emerging Market Trends Driving the Growth of the Infusion Therapy Devices Industry?

Leading companies in the infusion therapy devices market are directing their efforts towards creating innovative solutions like the pressure-enabled drug delivery (PEDD) technology. This novel technology is set up to improve treatments for liver and pancreatic tumors. The PEDD technology uses pressure to enhance the delivery of therapeutic agents into tissues or organs, proving to be more efficient in areas where traditional methods may encounter difficulties. For example, in November 2024, the medical technology firm based in the US, TriSalus Life Sciences, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters. This broadened the company’s PEDD offerings, improving delivery, expanding treatment choices, and potentially enhancing patient outcomes. The TriNav LV Infusion System has distinctive features such as larger blood vessels (3.5 to 5.0 mm), making TriSalus’ PEDD technology available to a larger group of patients. The launch expanded the PEDD device’s compatibility to vessels ranging from 1.5 mm to 5.0 mm, giving interventional radiologists more options for treatments. The TriGuide Guiding Catheters are designed with a larger inner diameter, a slick lining, and a reversed curve design for a simpler femoral access and better procedural efficacy. Preliminary users reported a satisfaction rate of 97%, reinforcing the system’s efficiency and user-friendliness in oncology treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

Which Regions Are Driving Growth in the Infusion Therapy Devices Market?

North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

This Report Delivers Insight On:

1. How big is the infusion therapy devices market, and how is it changing globally?

2. Who are the major companies in the infusion therapy devices market, and how are they performing?

3. What are the key opportunities and risks in the infusion therapy devices market right now?

4. Which products or customer segments are growing the most in the infusion therapy devices market?

5. What factors are helping or slowing down the growth of the infusion therapy devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model